Table 1 Characteristics of patients
|  | Patients number = 99 |
|---|---|
Age, year | 69 (53–74) |
Male, n (%) | 68 (68.7) |
Height, cm | 165 (155–171) |
Body weight, kg | 65 (53–75) |
APACHE II score | 24 (18–32) |
Primary disease for admission, n (%) | |
 Cardiac arrest | 22 (22.2) |
 Cardiovascular disease | 17 (17.2) |
 Sepsis | 16 (16.2) |
 Burn | 10 (10.1) |
 Trauma | 7 (7.1) |
 Cerebral vascular disease | 6 (6.1) |
 COVID-19 | 5 (5.1) |
 Pulmonary embolism | 2 (2.0) |
 Other | 14 (14.1) |
Purpose for heparin administration, n (%) | |
 Prevention for DVT | 34 (34.3) |
 ECMO | 29 (29.3) |
 Atrial fibrillation | 13 (13.1) |
 Treatment for DVT/PE | 10 (10.1) |
 CRRT | 7 (7.1) |
 Other | 6 (6.1) |
Heparin dosage (units/h) | 600 (400–800) |